Home › CVAC
Biotechnology
CVAC
6.50
  Price6.20%   -0.43
(After Hours: 6.55 +0.05 +0.77% )
loading

KEY STATS

Previous Close:
$6.93
Market Cap:
$1.44B
24h Volume:
748.27K
1D Range:
$6.49 - $6.93
52W Range:
$5.63 - $20.45
Primary Exchange:

COMPANY PROFILE

NameNameCurevac N V
sectorSectorHealthcare (1488)
industryIndustryBiotechnology (860)
webWebcurevac.com
phonePhone49 7 0719 8830
employeeEmployee0
chart-line-icon Latest SEC Filings
twitter-icon CVAC's Discussions on Twitter
locationFriedrich-Miescher-Strasse 15, Tübingen, null, Germany (72076)

CVAC’s Recommendation Trends & Predictions

Buy
0%
Hold
0%
Sell
0%

UPGRADES & DOWNGRADES

Upgrade UBS: Neutral → Buy Jan-19-23
Upgrade Jefferies: Hold → Buy Jan-09-23
Downgrade BofA Securities: Neutral → Underperform Jan-21-22
Initiated JMP Securities: Mkt Outperform Jan-18-22
Initiated Deutsche Bank: Hold Oct-22-21
Downgrade BofA Securities: Buy → Neutral Jun-17-21
Resumed Credit Suisse: Underperform Apr-26-21
Initiated Guggenheim: Neutral Apr-26-21
Downgrade Credit Suisse: Neutral → Underperform Dec-10-20
Initiated BofA Securities: Buy Sep-08-20
Initiated Credit Suisse: Neutral Sep-08-20
Initiated Jefferies: Hold Sep-08-20
More Upgrades & Downgrades
News Options Chain Financials Insider Trading Why CVAC Down? Discussions Forecast

Curevac N V Stock (CVAC) Latest News

Jan-20-23 02:11AM Omicron subvariant gains more ground in U.S. to account for 49.1% of new COVID cases, CDC data showMarketWatch
Jan-19-23 01:33AM Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionBenzinga
10:37AM Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On ThursdayBenzinga
Jan-19-23 10:01AM Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023Benzinga
07:48AM Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving PremarketBenzinga
Jan-19-23 06:09AM Nasdaq, S&P 500 Futures Slump Ahead Of Netflix Earnings, Another Batch Of Economic DataBenzinga
Jan-12-23 06:01AM Oramed Pharmaceuticals, Logitech International And Some Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga
Jan-11-23 11:30AM CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On WednesdayBenzinga
09:17AM Company News for Jan 11, 2023Zacks Investment Research
Jan-11-23 06:18AM World Wrestling Entertainment, Bed Bath & Beyond And Other Big Stocks Moving Higher In Wednesday's Pre-Market SessionBenzinga
06:17AM Nasdaq, S&P 500 Futures Edge Up As Inflation Jitters Keep Sentiment MutedBenzinga
Jan-10-23 02:11AM Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionBenzinga
Jan-09-23 02:19AM Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government's pandemic responseMarketWatch
01:42AM Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day SessionBenzinga
Jan-09-23 10:39AM Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government's pandemic responseMarketWatch
10:36AM Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On MondayBenzinga
Jan-09-23 10:01AM Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023Benzinga
08:04AM Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving PremarketBenzinga
Jan-09-23 06:14AM US Stocks Look Set To Carry Last Week's Momentum Forward On Monday — Focus Now On Inflation Data, Q4 Reporting SeasonBenzinga
Jan-06-23 01:16AM Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day SessionBenzinga
Nov-22-22 09:55AM Wall Street Analysts Believe CureVac N.V. (CVAC) Could Rally 139%: Here's is How to TradeZacks Investment Research
Nov-15-22 05:19AM Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From YesterdayBenzinga
02:34AM Miniso Group, Monday.com And Other Big Gainers From MondayBenzinga
Oct-12-22 10:01AM Dow Gains Over 50 Points; US Producer Prices Rise 0.4% In SeptemberBenzinga
Sep-28-22 09:31AM Bet on These 4 Biotech Stocks With Bright ProspectsZacks Investment Research
Sep-23-22 03:42AM Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From YesterdayBenzinga

About Curevac N V

CureVac B.V., a clinical-stage biopharmaceutical company, engages in developing medicines based on messenger ribonucleic acid. The company's lead clinical programs include CV8102 that is in a Phase I clinical trial for the treatment of various types of solid tumors; and CV7202, which is investigating in a Phase I clinical trial for vaccination against rabies. It is also advancing mRNA vaccine program against coronavirus (SARS-CoV-2), which is in Phase I clinical trial. The company has collaboration and license agreements with GlaxoSmithKline Biologicals SA, Genmab B.V., Boehringer Ingelheim GmbH, and Eli Lilly and Company; development and option agreements with Arcturus Therapeutics, Inc., Acuitas Therapeutics Inc., and CRISPR Therapeutics AG; and a development and intellectual property agreement with Tesla Grohmann Automation GmbH. CureVac B.V. was founded in 2000 and is headquartered in Tübingen, Germany.
Real-Time Dow Stock List Congresswoman Nancy Pelosi Stock Tracker Top 100 popular stocks on Robinhood
Open in Yahoo | Open in Google | Open in Finviz
Cap:     |  Volume (24h):